Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes

Lignende værker

• Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes
  af: Baker, D J, et al.
  Udgivet: (2014)
• The APOE(∗)3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis
  af: Pouwer, Marianne G., et al.
  Udgivet: (2019)
• Production of a mouse strain with impaired glucose tolerance by systemic heterozygous knockout of the glucokinase gene and its feasibility as a prediabetes model
  af: SAITO, Mikako, et al.
  Udgivet: (2015)
• Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice
  af: Adingupu, Damilola D., et al.
  Udgivet: (2016)
• Characterization of the gene expression profile of heterozygous liver-specific glucokinase knockout mice at a young age
  af: Guo, Tingting, et al.
  Udgivet: (2012)